Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Axsome Therapeutics, Inc. (AXSM)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Axsome Therapeutics, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Axsome Therapeutics, Inc. since 2005.
The reporting company's ticker symbol is AXSM. The reporting company's CIK number is 1579428.
The total value of stock buying since 2005 is $234,698.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $183,338.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-03-19||Pizzie Nick (Chief Financial Officer)||Buy||5,400||12.63||68,229|
|2019-03-19||Coleman Mark (Director)||Buy||5,100||12.18||62,118|
|2018-06-19||Pizzie Nick (Chief Financial Officer)||Buy||31,000||3.08||95,325|
|2017-03-29||Jeffs Roger (Director)||Option Ex||42,538||4.31||183,338|
|2015-12-23||Kaye Randall (Chief Medical Officer)||Buy||1,000||9.03||9,026|
Insider trading activities including stock purchases, stock sales, and option exercises of AXSM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Axsome Therapeutics, Inc. (symbol AXSM, CIK number 1579428) see the Securities and Exchange Commission (SEC) website.